79111670 - EXONHIT

Information

• Trademark
• 79111670

• Source

• Serial Number

  79111670

• Registration Number

  4281253

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  November 30, 2011
  13 years ago

• Registration Date

  January 29, 2013
  11 years ago

• Transaction Date

  June 26, 2022
  2 years ago

• Status Date

  November 30, 2021
  3 years ago

• Published for Opposition Date

  November 13, 2012
  12 years ago

• Location Date

  January 29, 2013
  11 years ago

• Status Code

  404

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  HOFFMAN, DAVID AARON

• Law Office Assigned Location Code

  L70

• Owners

  • DIAXONHIT
  • Exonhit S.A.

Case File Statements

• DM0000: The mark consists of the wording "EXONHIT" in stylized format. "EXON" is in grey and "HIT" is in burgundy.
• GS0051: Pharmaceutical products for the treatment of diseases, namely, Alzheimer disease and other neurodegenerative diseases and cancer; reagents and consumables for diagnostic purposes and diagnostic media intended for medical purposes, namely, reagents, consumables and media intended for tests, namely, tests based on blood biomarkers for identifying patients affected by diseases or those at risk of developing a disease and for identifying patients responding to specific personalized treatments; biological acidic products and preparations for pharmaceutical purposes, namely, pharmaceutical preparations for diagnosing diseases, namely, Alzheimer disease and other neurodegenerative diseases and cancer; capsules sold empty for medicines and diagnostic tests; chemico-pharmaceutical preparations for diagnosing, preventing and treating diseases, namely, Alzheimer disease and other neurodegenerative diseases and, cancer; biopharmaceutical products, namely, reagents, consumables, chemical entities and compounds for diagnosing, preventing and treating diseases, namely, Alzheimer disease and other neurodegenerative diseases and cancer ; chemical preparations for medical, pharmaceutical or veterinary purposes, namely, chemicals for diagnosing Alzheimer disease and other neurodegenerative diseases and cancer, especially chemical preparations for diagnosing diseases in the nature of neurodegenerative diseases and cancers; medical diagnostic products and clinical diagnostic products, namely, probes and kits for medical and clinical diagnosis comprised of nucleic acid libraries and nucleic acids on DNA chips; DNA libraries and RNA libraries for medical diagnostic purposes; nucleic acid sequences intended for use in chips for medical purposes and medical diagnostic purposes, namely, for decoding genes affected by diseases or revealing the transcriptomic signature of patients affected by diseases; enzymes or enzyme preparations for medical or veterinary purposes, namely, enzyme stabilizers and enzymatic substrates for use as ingredients in medicines for the treatment of diseases; reagents contained in diagnostic test kits for medical use for taking blood samples required for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions
• CC0000: The color(s) grey and burgundy is/are claimed as a feature of the mark.
• GS0011: Chemical products and compositions, namely, nucleic acids attached to a solid medium for industrial and scientific use; fissile chemical elements intended for scientific research or laboratory research, namely, reagents, consumables, chemical entities and compounds; chemical preparations for nucleic acids attached to a solid medium for scientific purposes, chemical preparations for scientific analyses other than for medical or veterinary purposes; biological preparations other than for medical or veterinary purposes, namely, blood for the quantification of nucleic acid content; chemical preparations for scientific purposes other than for medical or veterinary use; chemical reagents or products for laboratory analyses, namely, nucleic acids for monitoring and analyzing the expression of genes, for identifying diagnostic targets and therapeutic products, and for conducting research on pharmacogenetics and genotoxicity in connection with pharmacology, food, chemistry, cosmetology, plant health and veterinary sciences; chemical preparations intended for scientific purposes, namely, libraries of nucleic acids for monitoring and analyzing the expression of genes, for identifying diagnostic targets and therapeutic products, and for leading research on pharmacogenetics and genotoxicity in connection with pharmacology, food, chemistry, cosmetology, plant health and veterinary sciences; chemical preparations intended for scientific purposes, namely, DNA fragments for decoding genes affected by diseases or for revealing the transcriptomic signature of patients affected by diseases, and DNA fragments for revealing and analyzing the expression of genes in connection with human medicine, pharmacological medicine and veterinary science
• GS0441: Medical services; veterinary services; medical assistance services; consultancy in the field of pharmacy, namely, to assist in the selection of individuals affected by diseases for the purpose of clinical trials and to offer targeted care solutions and personalized treatments; hospitals; pharmaceutical industry services, namely, to provide advice in the fields of biotechnology and pharmacy; and pharmacist's services to make up prescriptions, namely, geriatric and/or neurological services, in order to facilitate diagnoses and treatment; health care; telemedicine services
• GS0101: Surgical, medical, dental and veterinary apparatus and instruments, particularly for identifying, assessing the seriousness of, assessing prognoses of, and measuring the progression of diseases, namely, Alzheimer disease and other neurodegenerative diseases, and cancer; medical devices using DNA chips for analyzing blood; apparatus for analyzing blood; apparatus intended for medical diagnosis, namely, materials for taking blood contained in kits for taking blood samples and comprised of medical instruments for taking blood; medical instruments for taking blood, collecting of DNA for diagnosing diseases, and materials required for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions, namely, tubes, syringes and storage containers; spoons for administering medicine; specially adapted containers for the application of medicines, namely, small bags and pouches for use in administering medicines; probes for medical purposes; syringes for medical purposes
• GS0421: Research and development for others of pharmaceutical molecules or biological markers for diagnostic purposes and medicines for treating diseases; chemical analyses; chemical research; chemical services, namely, analysis of RNA genes, tissues and blood samples; biotechnological scientific project studies for identifying people suffering from diseases and to measure the seriousness, prognoses, progression and conversion of the disease and to determine how patients respond to treatments, especially personalized treatments; research and development of new products for others; biological research; biotechnological research; technical research in the field of biotechnology; biotechnological analysis services; laboratory analyses, namely, quantification of nucleic acid content intended for medical and scientific research; consultancy in the field of biotechnology

Case File Event Statements

• 6/26/2022 - 2 years ago

  43 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED Type: DENC

• 6/26/2022 - 2 years ago

  42 - DEATH OF INTERNATIONAL REGISTRATION Type: DETH

• 7/17/2020 - 4 years ago

  41 - TOTAL INVALIDATION PROCESSED BY THE IB Type: INNT

• 6/15/2020 - 4 years ago

  40 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INTS

• 6/15/2020 - 4 years ago

  39 - INVALIDATION PROCESSED Type: INPC

• 4/30/2020 - 4 years ago

  38 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR

• 8/30/2019 - 5 years ago

  37 - CANCELLED SECTION 71 Type: C71T

• 1/29/2018 - 6 years ago

  36 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3

• 11/20/2014 - 10 years ago

  35 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH

• 5/25/2013 - 11 years ago

  34 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 4/29/2013 - 11 years ago

  33 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 4/29/2013 - 11 years ago

  32 - FINAL DISPOSITION PROCESSED Type: FIMP

• 4/29/2013 - 11 years ago

  31 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 1/29/2013 - 11 years ago

  30 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 11/18/2012 - 12 years ago

  29 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 11/13/2012 - 12 years ago

  28 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 11/13/2012 - 12 years ago

  27 - PUBLISHED FOR OPPOSITION Type: PUBO

• 10/24/2012 - 12 years ago

  26 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 10/24/2012 - 12 years ago

  25 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 10/24/2012 - 12 years ago

  24 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 10/9/2012 - 12 years ago

  23 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 10/5/2012 - 12 years ago

  22 - ASSIGNED TO LIE Type: ALIE

• 9/22/2012 - 12 years ago

  21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 9/21/2012 - 12 years ago

  20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 9/21/2012 - 12 years ago

  19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 9/21/2012 - 12 years ago

  18 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 8/27/2012 - 12 years ago

  17 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 8/27/2012 - 12 years ago

  16 - FINAL REFUSAL E-MAILED Type: GNFR

• 8/27/2012 - 12 years ago

  15 - FINAL REFUSAL WRITTEN Type: CNFR

• 7/23/2012 - 12 years ago

  14 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 7/23/2012 - 12 years ago

  13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 7/23/2012 - 12 years ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/23/2012 - 12 years ago

  11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 6/11/2012 - 12 years ago

  10 - REFUSAL PROCESSED BY IB Type: RFNT

• 5/18/2012 - 12 years ago

  9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 5/18/2012 - 12 years ago

  8 - REFUSAL PROCESSED BY MPU Type: RFRR

• 5/17/2012 - 12 years ago

  7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 5/16/2012 - 12 years ago

  6 - NON-FINAL ACTION WRITTEN Type: CNRT

• 5/14/2012 - 12 years ago

  5 - ASSIGNED TO EXAMINER Type: DOCK

• 5/8/2012 - 12 years ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 5/4/2012 - 12 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 5/4/2012 - 12 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 5/3/2012 - 12 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR